Rheumatic Heart Disease in Indigenous Populations-New Zealand Experience

Heart Lung and Circulation

Volumn 19, Issue 5-6, 2010, Pages 282-288

  Wilson, Nigel ^a  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

Indigenous health; Rheumatic heart disease

Indexed keywords

BENZATHINE PENICILLIN; IMMUNOGLOBULIN; PENICILLIN G;

ALLERGIC REACTION; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FAILURE; HUMAN; INDIGENOUS PEOPLE; MITRAL VALVE REPAIR; NEW ZEALAND; PATIENT ASSESSMENT; PATIENT COMPLIANCE; POSTPARTUM HEMORRHAGE; PRIMARY PREVENTION; PRIORITY JOURNAL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; STREPTOCOCCAL PHARYNGITIS; THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CARDIAC SURGICAL PROCEDURES; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SERVICES, INDIGENOUS; HEALTHCARE DISPARITIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; NEW ZEALAND; OCEANIC ANCESTRY GROUP; OUTCOME ASSESSMENT (HEALTH CARE); POPULATION GROUPS; PREVALENCE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 77953122861     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2010.02.021     Document Type: Article

References (60)

1. Thornley C. Rheumatic fever registers in New Zealand. Public Health Rep 2001, 41-44.
2. Spinetto H. Recurrences of rheumatic fever in Auckland 1993-1999. Nursing Thesis, Auckland, 2003.
3. New Zealand Guidelines for Rheumatic fever 1. Diagnosis, Management and Secondary prevention. Heart Foundation of New Zealand, Cardiac Society of Australia and New Zealand, 2006. Accessed September 2009. http://www.nhf.org.nz/.
4. Atatoa-Carr P., Lennon D., Wilson N. Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline. N Z Med J 2008, 121(1271):59-69.
5. Jaine R., Baker M., Venugopal K. Epidemiology of acute rheumatic fever in New Zealand 1996-2005. J Paediatr Child Health 2008 Oct, 44(10):564-571.
6. Lennon D. Acute rheumatic fever. In: Pediatrics, 5th ed. Philadelphia: WB Saunders; 2004.
7. Frankish J.D., Stanhope J.M., Martin D.R., Clarkson P.M., Leslie P.N., Langley R.B. Rheumatic fever and streptococci: the Wairoa College study. N Z Med J 1978, 87(604):33-38.
8. Christmas B.W. Management of rheumatic fever: a review. N Z Med J 1984, 97(763):598-600.
9. Neutze J.M., Clarkson P.M. Rheumatic fever: an unsolved problem in New Zealand. N Z Med J 1984, 97(763):591-593.
10. Wabitsch K.R., Prior I.A., Stanley D.G., Pearce N. New Zealand trends in acute rheumatic fever and chronic rheumatic heart disease 1971-1981. N Z Med J 1984, 97(763):594-597.
11. Stanhope J.M. New Zealand trends in rheumatic fever: 1885-1971. N Z Med J 1975, 82(551):297-299.
12. Proceedings of the Third International Conference on Rheumatic Fever and Rheumatic Heart disease. Rotorua, 16-18 April 1987. N Z Med J 1988;101(847):378-411.
13. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. International Rheumatic Fever Study Group. Lancet 1991;337(8753):1308-10.
14. Martin D.R. Streptococci and rheumatic fever: a review. N Z Med J 1984, 97(764):629-630.
15. Martin D.R. Rheumatogenic streptococci reconsidered. N Z Med J 1988, 101(847):394-396.
16. Martin D.R., Voss L.M., Walker S.J., Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994, 13(4):264-269.
17. Lennon D., Martin D., Wong E., Taylor L.R. Longitudinal study of poststreptococcal disease in Auckland; rheumatic fever, glomerulonephritis, epidemiology and M typing 1981-86. N Z Med J 1988, 101(847):396-398.
18. McDonald M., Currie B.J., Carapetis J.R. Acute rheumatic fever: a chink in the chain that links the heart to the throat?. Lancet Infect Dis 2004, 4(4):240-245.
19. Jaffe W.M., Roche A.H., Coverdale H.A., McAlister H.F., Ormiston J.A., Greene E.R. Clinical evaluation versus Doppler echocardiography in the quantitative assessment of valvular heart disease. Circulation 1988, 78(2):267-275.
20. Wilson N.J., Neutze J.M. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int J Cardiol 1995, 50(1):1-6.
21. Abernethy M., Bass N., Sharpe N., Grant C., Neutze J., Clarkson P., Greaves S., Lennon D., Snow S., Whalley G. Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever. Aust N Z J Med 1994, 24(5):530-535.
22. Wilson NJ, Voss LM, Neutze JM, Ameratunga RV, Lennon DR. The natural history of acute rheumatic fever to one year in the echocardiographic era. In: Proceedings of the 2nd World Congress of Paediatric Cardiology and Cardiac Surgery. New York: Futura Publishing Co.; 1997. p. 971-2.
23. Mota C.C. Doppler echocardiographic assessment of subclinical valvitis in the diagnosis of acute rheumatic fever. Cardiol Young 2001, 11(3):251-254.
24. Tubridy-Clark M., Carapetis J.R. Subclinical carditis in rheumatic fever: a systematic review. Int J Cardiol 2007, 119(1):54-58.
25. Wilson N. Echocardiography and subclinical carditis: guidelines that increase sensitivity for acute rheumatic fever. Cardiol Young 2008, 18:565-568.
26. Ozkutlu S., Ayabakan C., Saraclar M. Can subclinical valvulitis detected by echocardiography be accepted as evidence of carditis in the diagnosis of acute rheumatic fever?. Cardiol Young 2001, 11(3):255-260.
27. Carapetis J.R., Brown A., Wilson N.J., Edwards K.N. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust 2007, 186(11):581-586.
28. Rheumatic fever and rheumatic heart disease. World Health Organization technical report series; 2004. p. 1-122.
29. Voss L.M., Wilson N.J., Neutze J.M., Whitlock R.M., Ameratunga R.V., Cairns L.M., Lennon D.R. Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial. Circulation 2001, 103(3):401-406.
30. Albert D.A., Harel L., Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995, 74(1):1-12.
31. Carapetis J.R., McDonald M., Wilson N.J. Acute rheumatic fever. Lancet 2005, 366(9480):155-168.
32. Gentles T.L., Colan S.D., Wilson N.J., Biosa R., Neutze J.M. Left ventricular mechanics during and after acute rheumatic fever: contractile dysfunction is closely related to valve regurgitation. J Am Coll Cardiol 2001, 37(1):201-207.
33. Essop M.R., Wisenbaugh T., Sareli P. Evidence against a myocardial factor as the cause of left ventricular dilation in active rheumatic carditis. J Am Coll Cardiol 1993, 22(3):826-829.
34. Wong S.P., French R.A., Bolson E.A., Legget M.E., Sheehan F.H. Morphology of the rheumatic mitral regurgitant valve by three-dimensional echocardiography. Am Heart J 2001, 142(5):897-907.
35. Enriquez-Sarano M., Schaff H.V., Orszulak T.A., Tajik A.J., Bailey K.R., Frye R.L. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995, 91(4):1022-1028.
36. Shuhaiber J., Anderson R.J. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg 2007, 31(2):267-275.
37. Neutze J.M. Rheumatic fever and rheumatic heart disease in the western Pacific region. N Z Med J 1988, 101(847):404-406.
38. Anderson Y., Wilson N., Nicholson R., Finucane K. Fulminant mitral regurgitation due to ruptured chordae tendinae in acute rheumatic fever. J Paediatr Child Health 2008, 44(3):134-137.
39. Barratt-Boyes B.G., Lowe J.B., Cole D.S., Kelly D.T. Homograft valve replacement for aortic valve disease. Thorax 1965, 20(6):495-504.
40. Barratt-Boyes B.G., Roche A.H., Subramanyan R., Pemberton J.R., Whitlock R.M. Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted freehand in the aortic position. Circulation 1987, 75(4):768-777.
41. Jaffe W.M., Barratt-Boyes B.G., Sadri A., Gavin J.B., Coverdale H.A., Neutze J.M. Early follow-up of patients with the Medtronic Intact porcine valve. A new cardiac bioprosthesis. J Thorac Cardiovasc Surg 1989, 98(2):181-192.
42. Wong S.P., Legget M.E., Greaves S.C., Barratt-Boyes B.G., Milsom F.P., Raudkivi P.J. Early experience with the mosaic bioprosthesis: a new generation porcine valve. Ann Thorac Surg 2000, 69(6):1846-1850.
43. North R.A., Sadler L., Stewart A.W., McCowan L.M., Kerr A.R., White H.D. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 1999, 99(20):2669-2676. [comment].
44. Sadler L., McCowan L., White H., Stewart A., Bracken M., North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br J Obstet Gynaecol 2000, 107(2):245-253.
45. North D.A., Heynes R.A., Lennon D.R., Neutze J. Analysis of costs of acute rheumatic fever and rheumatic heart disease in Auckland. N Z Med J 1993, 106(964):400-403.
46. Lund M., Ellis C.J., Coverdale H.A., Agnew T.M., Haydock D.A., Middleton N.G., Whitfield C.J., Whitlock R.M. Cardiac transplantation in New Zealand: eight years experience. N Z Med 1997, 110(1042):139-142.
47. Lennon D., Stewart J., Farrell E., Palmer A., Mason H. School-based prevention of acute rheumatic Fever: a group randomized trial in New Zealand. Pediatr Infect Dis J 2009, 28:787-794.
48. Lennon D., Kerdemelidis M., Arroll B. Meta-analysis of trials of streptococcal throat treatment programs to prevent rheumatic fever. Pediatr Infect Dis J 2009, 28(7):e259-e264.
49. New Zealand Guidelines for Rheumatic fever 3. Proposed rheumatic fever primary prevention programme. Heart Foundation of New Zealand, Cardiac Society of Australia and New Zealand, 2009. Accessed January 2010. http://www.nhf.org.nz/.
50. New Zealand Guidelines for Rheumatic fever 2. Diagnosis. Sore throat management. Heart Foundation of New Zealand, Cardiac Society of Australia and New Zealand, 2009. Accessed December 2009. http://www.nhf.org.nz/.
51. Declaration on the Rights of Indigenous Peoples, United Nations General Assembly, 2008.
52. Pomare E., de Boer G. Hauora:Maori standards of health 1988, Department of Health, Wellington.
53. Manyemba J., Mayosi B.M. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 2002, (3). CD002227.
54. Frankish J.D. Rheumatic fever prophylaxis:Gisborne experience. N Z Med J 1984, 97:674-675.
55. Newman J.E., Lennon D.R., Wong-Toi W. Patients with rheumatic fever recurrences. N Z Med J 1984, 97(765):678-680.
56. Talbot R.G. Rheumatic fever and rheumatic heart disease in the Hamilton health district: II. Long term follow-up and secondary prophylaxis. N Z Med J 1984, 97(764):634-637.
57. Grayson S., Horsburgh M., Lennon D. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J 2006, 119:2255.
58. Webb R, Wilson N, Lennon D, Trenholme A, Wilson E, Nicholson R, Gentles T, O'Donell C, Stiriling J, Zeng I. Population-based echocardiographic screening for Rheumatic Heart Disease in high-risk New Zealand children. Abstract. World Congress Paediatric Cardiology and Cardiac Surgery, Cairns, 2009.
59. Marijon E., Ou P., Celermajer D.S., Ferreira B., Mocumbi A.O., Jani D., Paquet C., Jacobs S., Sidi D., Jouven X. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007, 357(5):470-476.
60. Carapetis J.R., Hardy M., Fakakovikaetau T., Taib R., Wilkinson L., Penny D.J., Steer A.C. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat Clin Pract Cardiovasc Med 2008, 5(7):411-417.